{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:55:05Z","timestamp":1794030905711,"version":"4.8.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s40257-019-00444-8","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T20:13:52Z","timestamp":1558556032000},"page":"669-682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Eruptive Melanocytic Nevi: A Review"],"prefix":"10.1007","volume":"20","author":[{"given":"Ewa A.","family":"Burian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor B. E.","family":"Jemec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"444_CR1","unstructured":"Hutchinson J. Outbreak of a large crop of moles. Remarks as to possible connection with melanosis. J Cutan Med Dis Skin. 1868:170\u2013171."},{"issue":"12","key":"444_CR2","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/archderm.1975.01630240114019","volume":"111","author":"RJ Coskey","year":"1975","unstructured":"Coskey RJ. Letter: eruptive nevi. Arch Dermatol. 1975;111(12):1658.","journal-title":"Arch Dermatol"},{"issue":"5","key":"444_CR3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1586\/era.11.30","volume":"11","author":"JK John","year":"2011","unstructured":"John JK, Smalley KS. Identification of BRAF mutations in eruptive melanocytic nevi: new insights into melanomagenesis? Expert Rev Anticancer Ther. 2011;11(5):711\u20134.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"6","key":"444_CR4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2310\/7750.2013.13034","volume":"17","author":"TG Salopek","year":"2013","unstructured":"Salopek TG, Mahmood MN. Eruptive melanocytic nevi induced by interferon for nodal metastatic melanoma: case report and review of the literature. J Cutan Med Surg. 2013;17(6):410\u20133.","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"444_CR5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-2133.2010.09989.x","volume":"163","author":"A Sekulic","year":"2010","unstructured":"Sekulic A, Colgan MB, Davis MD, et al. Activating BRAF mutations in eruptive melanocytic naevi. Br J Dermatol. 2010;163(5):1095\u20138.","journal-title":"Br J Dermatol"},{"issue":"12","key":"444_CR6","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archderm.143.12.1555","volume":"143","author":"A Gelfer","year":"2007","unstructured":"Gelfer A, Rivers JK. Long-term follow-up of a patient with eruptive melanocytic nevi after Stevens-Johnson syndrome. Arch Dermatol. 2007;143(12):1555\u20137.","journal-title":"Arch Dermatol"},{"issue":"8","key":"444_CR7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archderm.141.8.998","volume":"141","author":"JP Banky","year":"2005","unstructured":"Banky JP, Kelly JW, English DR, et al. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol. 2005;141(8):998\u20131006.","journal-title":"Arch Dermatol"},{"issue":"3","key":"444_CR8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.0022-202x.2001.01685.x","volume":"118","author":"V Siskind","year":"2002","unstructured":"Siskind V, Darlington S, Green L, et al. Evolution of melanocytic nevi on the faces and necks of adolescents: a 4 y longitudinal study. J Invest Dermatol. 2002;118(3):500\u20134.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"444_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2133.1985.tb02060.x","volume":"113","author":"RM MacKie","year":"1985","unstructured":"MacKie RM, English J, Aitchison TC, et al. The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol. 1985;113(2):167\u201374.","journal-title":"Br J Dermatol"},{"issue":"3","key":"444_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00008390-200506000-00014","volume":"15","author":"Anna Belloni Fortina","year":"2005","unstructured":"Belloni Fortina A, Piaserico S, Zattra E, et al. Dermoscopic features of eruptive melanocytic naevi in an adult patient receiving immunosuppressive therapy for Crohn\u2019s disease. Melanoma Res. 2005;15(3):223\u20134.","journal-title":"Melanoma Research"},{"issue":"5","key":"444_CR11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.crohns.2012.02.008","volume":"6","author":"J Wonders","year":"2012","unstructured":"Wonders J, De Boer NK, Van Weyenberg SJ. Spot diagnosis: eruptive melanocytic naevi during azathioprine therapy in Crohn\u2019s disease. J Crohns Colitis. 2012;6(5):636.","journal-title":"J Crohns Colitis"},{"issue":"5 Suppl 1","key":"444_CR12","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.jaad.2004.08.009","volume":"52","author":"J Woodhouse","year":"2005","unstructured":"Woodhouse J, Maytin EV. Eruptive nevi of the palms and soles. J Am Acad Dermatol. 2005;52(5 Suppl 1):S96\u2013100.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"444_CR13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-4632.2005.02086.x","volume":"44","author":"M Kakrida","year":"2005","unstructured":"Kakrida M, Orengo I, Markus R. Sudden onset of Multiple nevi after administration of 6-mercaptopurine in an adult with Crohn\u2019s disease: a case report. Int J Dermatol. 2005;44(4):334\u20136.","journal-title":"Int J Dermatol"},{"issue":"7","key":"444_CR14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archdermatol.2010.145","volume":"146","author":"V Lopez","year":"2010","unstructured":"Lopez V, Molina I, Martin JM, et al. Eruptive nevi in a patient receiving cyclosporine A for psoriasis treatment. Arch Dermatol. 2010;146(7):802\u20134.","journal-title":"Arch Dermatol"},{"issue":"6","key":"444_CR15","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1002\/ibd.21618","volume":"17","author":"NK de Boer","year":"2011","unstructured":"de Boer NK, Kuyvenhoven JP. Eruptive benign melanocytic naevi during immunosuppressive therapy in a Crohn\u2019s disease patient. Inflamm Bowel Dis. 2011;17(6):E26.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"444_CR16","doi-asserted-by":"crossref","first-page":"18184","DOI":"10.5070\/D3195018184","volume":"19","author":"EE Uhlenhake","year":"2013","unstructured":"Uhlenhake EE, Watson AC, Aronson P. Sorafenib induced eruptive melanocytic lesions. Dermatol Online J. 2013;19(5):18184.","journal-title":"Dermatol Online J"},{"issue":"5","key":"444_CR17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/jamadermatol.2013.263","volume":"149","author":"D Jimenez-Gallo","year":"2013","unstructured":"Jimenez-Gallo D, Albarran-Planelles C, Linares-Barrios M, et al. Eruptive melanocytic nevi in a patient undergoing treatment with sunitinib. JAMA Dermatol. 2013;149(5):624\u20136.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"444_CR18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00128071-200910040-00006","volume":"10","author":"G Villalon","year":"2009","unstructured":"Villalon G, Martin JM, Pinazo MI, et al. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine. Am J Clin Dermatol. 2009;10(4):261\u20133.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"444_CR19","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0190-9622(03)02482-4","volume":"49","author":"M Alaibac","year":"2003","unstructured":"Alaibac M, Piaserico S, Rossi CR, et al. Eruptive melanocytic nevi in patients with renal allografts: report of 10 cases with dermoscopic findings. J Am Acad Dermatol. 2003;49(6):1020\u20132.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"444_CR20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1365-2133.2006.07189.x","volume":"154","author":"HJ Bovenschen","year":"2006","unstructured":"Bovenschen HJ, Tjioe M, Vermaat H, et al. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals. Br J Dermatol. 2006;154(5):880\u20134.","journal-title":"Br J Dermatol"},{"issue":"4","key":"444_CR21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1590\/S0365-05962011000400017","volume":"86","author":"JN Melo","year":"2011","unstructured":"Melo JN, Teruya PY, Machado MC, et al. Epidermolysis bullosa nevi: clinical, dermatoscopical and histological features in a case of recessive dystrofic form. An Bras Dermatol. 2011;86(4):743\u20136.","journal-title":"An Bras Dermatol"},{"issue":"9","key":"444_CR22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jamadermatol.2016.1150","volume":"152","author":"V Ratushny","year":"2016","unstructured":"Ratushny V, Kraft S, Moschella SL, et al. A symmetric eczematous eruption harboring thousands of melanocytic lesions. JAMA Dermatol. 2016;152(9):1021\u20134.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"444_CR23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000356389","volume":"228","author":"KF Hjuler","year":"2014","unstructured":"Hjuler KF, Lorentzen HF. Melanoma associated with the use of melanotan-II. Dermatology. 2014;228(1):34\u20136.","journal-title":"Dermatology"},{"issue":"6","key":"444_CR24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1365-2133.2011.10273.x","volume":"164","author":"D Paurobally","year":"2011","unstructured":"Paurobally D, Jason F, Dezfoulian B, et al. Melanotan-associated melanoma. Br J Dermatol. 2011;164(6):1403\u20135.","journal-title":"Br J Dermatol"},{"key":"444_CR25","unstructured":"Donati, P., G. Paolino, M. Donati, et al., Cutaneous mastocytosis combined with eruptive melanocytic nevi and melanoma. Coincidence or a linkage in the pathogenesis? J Dermatol Case Rep. 2014;8(3):70\u20134."},{"issue":"4","key":"444_CR26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/ajd.12724","volume":"58","author":"P Munguia-Calzada","year":"2017","unstructured":"Munguia-Calzada P, Vivanco B, Oliva-Nacarino P, et al. Melanoma, eruptive naevi and natalizumab: causal relation or coincidence? Australas J Dermatol. 2017;58(4):330\u20131.","journal-title":"Australas J Dermatol"},{"issue":"2","key":"444_CR27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1525-1470.2007.00359.x","volume":"24","author":"JC Reutter","year":"2007","unstructured":"Reutter JC, Long EM, Morrell DS, et al. Eruptive post-chemotherapy in situ melanomas and dysplastic nevi. Pediatr Dermatol. 2007;24(2):135\u20137.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"444_CR28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000063905","volume":"205","author":"T Bogenrieder","year":"2002","unstructured":"Bogenrieder T, Weitzel C, Scholmerich J, et al. Eruptive multiple lentigo-maligna-like lesions in a patient undergoing chemotherapy with an oral 5-fluorouracil prodrug for metastasizing colorectal carcinoma: a lesson for the pathogenesis of malignant melanoma? Dermatology. 2002;205(2):174\u20135.","journal-title":"Dermatology"},{"issue":"1","key":"444_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000350288","volume":"5","author":"L Schmitt","year":"2013","unstructured":"Schmitt L, Schumann T, Inhoff O, et al. Eruptive nevi mimicking wart-like lesions under selective BRAF inhibition in a 37-year-old female melanoma patient. Case Rep Dermatol. 2013;5(1):69\u201372.","journal-title":"Case Rep Dermatol"},{"issue":"2","key":"444_CR30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1440-0960.2012.00937.x","volume":"54","author":"SJ Arnold","year":"2013","unstructured":"Arnold SJ, Bowling J. Eruptive acral naevi following chemotherapy for acute lymphoblastic leukaemia follow typical acral dermoscopic patterns. Australas J Dermatol. 2013;54(2):126\u20138.","journal-title":"Australas J Dermatol"},{"issue":"12","key":"444_CR31","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/2013.jamadermatol.23","volume":"148","author":"L Ma","year":"2012","unstructured":"Ma L, Dominguez AR, Collins GR, et al. Hidradenitis suppurativa, eruptive melanocytic nevi, and keratosis pilaris-like eruption in a patient treated with vemurafenib. Arch Dermatol. 2012;148(12):1428\u20139.","journal-title":"Arch Dermatol"},{"issue":"12","key":"444_CR32","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/jdv.12110","volume":"27","author":"I Zalaudek","year":"2013","unstructured":"Zalaudek I, Moscarella E, Sturm RA, et al. \u2018Eruptive\u2019 amelanotic compound nevi in children with facial freckles and pale skin colour: more than an occasion? J Eur Acad Dermatol Venereol. 2013;27(12):1583\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"444_CR33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1684\/ejd.2014.2462","volume":"25","author":"V Sibaud","year":"2015","unstructured":"Sibaud V, Munsch C, Lamant L. Eruptive nevi and hair depigmentation related to regorafenib. Eur J Dermatol. 2015;25(1):85\u20136.","journal-title":"Eur J Dermatol"},{"issue":"3","key":"444_CR34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archderm.1989.01670150087015","volume":"125","author":"M Duvic","year":"1989","unstructured":"Duvic M, Lowe L, Rapini RP, et al. Eruptive dysplastic nevi associated with human immunodeficiency virus infection. Arch Dermatol. 1989;125(3):397\u2013401.","journal-title":"Arch Dermatol"},{"issue":"2","key":"444_CR35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2005.06.023","volume":"54","author":"S Piaserico","year":"2006","unstructured":"Piaserico S, Alaibac M, Fortina AB, et al. Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy. J Am Acad Dermatol. 2006;54(2):338\u201340.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"444_CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2340\/00015555-2475","volume":"97","author":"M Kim","year":"2017","unstructured":"Kim M, Yoon YH, Lee JH, et al. Eruptive melanocytic naevi caused by radotinib therapy in patients with chronic myeloid leukaemia: 10 cases and a literature review. Acta Derm Venereol. 2017;97(1):115\u20136.","journal-title":"Acta Derm Venereol"},{"key":"444_CR37","unstructured":"Burian, E. and E. Burian, [Eruptive nevi after injection of drugs marketed as melanotan II. The first two Swedish cases described]. Lakartidningen. 2013;110(5):208\u201310."},{"issue":"13","key":"444_CR38","first-page":"975","volume":"173","author":"K Thestrup-Pedersen","year":"2011","unstructured":"Thestrup-Pedersen K, Sondergaard K. Melanotan-induced lentigines and nevi. Ugeskr Laeger. 2011;173(13):975.","journal-title":"Ugeskr Laeger"},{"issue":"4","key":"444_CR39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archdermatol.2008.623","volume":"145","author":"AR Cardones","year":"2009","unstructured":"Cardones AR, Grichnik JM. alpha-Melanocyte-stimulating hormone-induced eruptive nevi. Arch Dermatol. 2009;145(4):441\u20134.","journal-title":"Arch Dermatol"},{"issue":"2","key":"444_CR40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000093859","volume":"213","author":"S Lebeau","year":"2006","unstructured":"Lebeau S, Braun RP, Masouye I, et al. Acquired melanocytic naevus in childhood vulval pemphigoid. Dermatology. 2006;213(2):159\u201362.","journal-title":"Dermatology"},{"issue":"9","key":"444_CR41","first-page":"1164","volume":"143","author":"SH Cash","year":"2007","unstructured":"Cash SH, Dever TT, Hyde P, et al. Epidermolysis bullosa nevus: an exception to the clinical and dermoscopic criteria for melanoma. Arch Dermatol. 2007;143(9):1164\u20137.","journal-title":"Arch Dermatol"},{"issue":"1","key":"444_CR42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/1346-8138.12655","volume":"42","author":"M Koga","year":"2015","unstructured":"Koga M, Koga K, Imafuku S. Spontaneous regression of an epidermolysis bullosa nevus on the sole. J Dermatol. 2015;42(1):37\u20139.","journal-title":"J Dermatol"},{"issue":"6","key":"444_CR43","doi-asserted-by":"crossref","first-page":"782","DOI":"10.5021\/ad.2015.27.6.782","volume":"27","author":"JH Lee","year":"2015","unstructured":"Lee JH, Kang JH, Cho BK, et al. Dysplastic nevus with eruptive melanocytic lesions that developed during nilotinib therapy for chronic myeloid leukemia. Ann Dermatol. 2015;27(6):782\u20134.","journal-title":"Ann Dermatol"},{"issue":"8","key":"444_CR44","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archderm.1977.01640080082014","volume":"113","author":"AW Kopf","year":"1977","unstructured":"Kopf AW, Grupper C, Baer RL, et al. Eruptive nevocytic nevi after severe bullous disease. Arch Dermatol. 1977;113(8):1080\u20134.","journal-title":"Arch Dermatol"},{"issue":"2 Pt 2","key":"444_CR45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0190-9622(97)80386-6","volume":"37","author":"T Shoji","year":"1997","unstructured":"Shoji T, Cockerell CJ, Koff AB, et al. Eruptive melanocytic nevi after Stevens-Johnson syndrome. J Am Acad Dermatol. 1997;37(2 Pt 2):337\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"444_CR46","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/archderm.1978.01640210079034","volume":"114","author":"G Goerz","year":"1978","unstructured":"Goerz G, Tsambaos D. Eruptive nevocytic nevi after Lyell\u2019s syndrome. Arch Dermatol. 1978;114(9):1400\u20131.","journal-title":"Arch Dermatol"},{"issue":"5","key":"444_CR47","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/00015550310012674","volume":"83","author":"CM Lanschuetzer","year":"2003","unstructured":"Lanschuetzer CM, Emberger M, Hametner R, et al. Pathogenic mechanisms in epidermolysis bullosa naevi. Acta Derm Venereol. 2003;83(5):332\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"444_CR48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2230.2003.01218.x","volume":"28","author":"CM Lanschuetzer","year":"2003","unstructured":"Lanschuetzer CM, Klausegger A, Pohla-Gubo G, et al. A novel homozygous nonsense deletion\/insertion mutation in the keratin 14 gene (Y248X; 744delC\/insAG) causes recessive epidermolysis bullosa simplex type Kobner. Clin Exp Dermatol. 2003;28(1):77\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"444_CR49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1525-1470.2005.22412.x","volume":"22","author":"F Gallardo","year":"2005","unstructured":"Gallardo F, Toll A, Malvehy J, et al. Large atypical melanocytic nevi in recessive dystrophic epidermolysis bullosa: clinicopathological, ultrastructural, and dermoscopic study. Pediatr Dermatol. 2005;22(4):338\u201343.","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"444_CR50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2133.1978.tb02028.x","volume":"99","author":"JD Kirby","year":"1978","unstructured":"Kirby JD, Darley CR. Eruptive melanocytic naevi following severe bullous disease. Br J Dermatol. 1978;99(5):575\u201380.","journal-title":"Br J Dermatol"},{"issue":"8","key":"444_CR51","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1468-3083.2011.04217.x","volume":"26","author":"N Erfan","year":"2012","unstructured":"Erfan N, Cardot-Leccia N, Sirvent A, et al. Eruptive nevi following bone marrow transplantation: a reflectance confocal microscopy study. J Eur Acad Dermatol Venereol. 2012;26(8):1043\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"444_CR52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-4632.2011.05253.x","volume":"52","author":"C McCourt","year":"2013","unstructured":"McCourt C, Feighery C, McIntyre G, et al. Eruptive nevi in prostate cancer: is this a paraneoplastic phenomenon? Int J Dermatol. 2013;52(2):212\u20133.","journal-title":"Int J Dermatol"},{"issue":"9","key":"444_CR53","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1365-4632.2011.05102.x","volume":"51","author":"C Lattouf","year":"2012","unstructured":"Lattouf C, Schachner L. Epidermolysis bullosa simplex, Dowling-Meara type with eruptive nevi. Int J Dermatol. 2012;51(9):1094\u20136.","journal-title":"Int J Dermatol"},{"issue":"4","key":"444_CR54","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000074124","volume":"207","author":"NG Stavrianeas","year":"2003","unstructured":"Stavrianeas NG, Katoulis AC, Moussatou V, et al. Eruptive large melanocytic nevus in a patient with hereditary epidermolysis bullosa simplex. Dermatology. 2003;207(4):402\u20134.","journal-title":"Dermatology"},{"issue":"4","key":"444_CR55","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1346-8138.1995.tb03390.x","volume":"22","author":"HW Bong","year":"1995","unstructured":"Bong HW, Lee SJ, Lee KH, et al. Disseminated eruptive nevocellular nevi. J Dermatol. 1995;22(4):292\u20137.","journal-title":"J Dermatol"},{"issue":"6","key":"444_CR56","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2230.2005.01822.x","volume":"30","author":"K Natsuga","year":"2005","unstructured":"Natsuga K, Akiyama M, Sato-Matsumura KC, et al. Two cases of atypical melanocytic lesions in recessive dystrophic epidermolysis bullosa infants. Clin Exp Dermatol. 2005;30(6):636\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"444_CR57","unstructured":"Dictionary.com. http:\/\/www.dictionary.com\/browse\/eruptive . [cited 2018 07 April]."},{"issue":"5","key":"444_CR58","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2016.04.064","volume":"75","author":"BM Perry","year":"2016","unstructured":"Perry BM, Nguyen A, Desmond BL, et al. Eruptive nevi associated with medications (ENAMs). J Am Acad Dermatol. 2016;75(5):1045\u201352.","journal-title":"J Am Acad Dermatol"},{"issue":"6691","key":"444_CR59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.299.6691.88","volume":"299","author":"BR Hughes","year":"1989","unstructured":"Hughes BR, Cunliffe WJ, Bailey CC. Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ. 1989;299(6691):88\u201391.","journal-title":"BMJ"},{"issue":"6857","key":"444_CR60","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/bmj.305.6857.799","volume":"305","author":"EA Baird","year":"1992","unstructured":"Baird EA, McHenry PM, MacKie RM. Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevi. BMJ. 1992;305(6857):799\u2013801.","journal-title":"BMJ"},{"issue":"3","key":"444_CR61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2133.2002.04748.x","volume":"147","author":"V Andreani","year":"2002","unstructured":"Andreani V, Richard MA, Blaise D, et al. Naevi in allogeneic bone marrow transplantation recipients: the effect of graft-versus-host disease on naevi. Br J Dermatol. 2002;147(3):433\u201341.","journal-title":"Br J Dermatol"},{"issue":"1","key":"444_CR62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0190-9622(93)70008-H","volume":"28","author":"CH Smith","year":"1993","unstructured":"Smith CH, McGregor JM, Barker JN, et al. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol. 1993;28(1):51\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"444_CR63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/1523-1747.ep12365586","volume":"107","author":"JJ Grob","year":"1996","unstructured":"Grob JJ, Bastuji-Garin S, Vaillant L, et al. Excess of nevi related to immunodeficiency: a study in HIV-infected patients and renal transplant recipients. J Invest Dermatol. 1996;107(5):694\u20137.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"444_CR64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000246050","volume":"194","author":"J Szepietowski","year":"1997","unstructured":"Szepietowski J, Wasik F, Szepietowski T, et al. Excess benign melanocytic naevi in renal transplant recipients. Dermatology. 1997;194(1):17\u20139.","journal-title":"Dermatology"},{"issue":"4","key":"444_CR65","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaad.2015.07.013","volume":"73","author":"G Koseoglu","year":"2015","unstructured":"Koseoglu G, Akay BN, Kucuksahin O, et al. Dermoscopic changes in melanocytic nevi in patients receiving immunosuppressive and biologic treatments: results of a prospective case-control study. J Am Acad Dermatol. 2015;73(4):623\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"444_CR66","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1402::AID-CNCR27>3.0.CO;2-4","volume":"77","author":"L Naldi","year":"1996","unstructured":"Naldi L, Adamoli L, Fraschini D, et al. Number and distribution of melanocytic nevi in individuals with a history of childhood leukemia. Cancer. 1996;77(7):1402\u20138.","journal-title":"Cancer"},{"key":"444_CR67","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000561","author":"E Crincoli","year":"2018","unstructured":"Crincoli E, Moliterni E, Catania F, et al. Correlation of serum tryptase levels with total number of nevi, Breslow thickness, ulceration, and mitotic index in melanoma patients: evaluation of a promising prognostic marker. Melanoma Res. 2018;. https:\/\/doi.org\/10.1097\/CMR.0000000000000561 .","journal-title":"Melanoma Res."},{"key":"444_CR68","doi-asserted-by":"crossref","first-page":"b566","DOI":"10.1136\/bmj.b566","volume":"338","author":"M Evans-Brown","year":"2009","unstructured":"Evans-Brown M, Dawson RT, Chandler M, et al. Use of melanotan I and II in the general population. BMJ. 2009;338:b566.","journal-title":"BMJ"},{"key":"444_CR69","first-page":"813513","volume":"2011","author":"AL Ross","year":"2011","unstructured":"Ross AL, Sanchez MI, Grichnik JM. Nevogenesis: a benign metastatic process? ISRN Dermatol. 2011;2011:813513.","journal-title":"ISRN Dermatol"},{"issue":"1","key":"444_CR70","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1097-0142(19910101)67:1<202::AID-CNCR2820670133>3.0.CO;2-H","volume":"67","author":"Gin Lee","year":"1991","unstructured":"Lee, G., M.C. Massa, S. Welykyj, et al., Yield from total skin examination and effectiveness of skin cancer awareness program. Findings in 874 new dermatology patients. Cancer. 1991;67(1):202\u20135.","journal-title":"Cancer"},{"issue":"8379","key":"444_CR71","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(84)92235-9","volume":"1","author":"WA Crutcher","year":"1984","unstructured":"Crutcher WA, Sagebiel RW. Prevalence of dysplastic naevi in a community practice. Lancet. 1984;1(8379):729.","journal-title":"Lancet"},{"issue":"2","key":"444_CR72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2133.1991.tb00424.x","volume":"124","author":"A Augustsson","year":"1991","unstructured":"Augustsson A, Stierner U, Suurkula M, et al. Prevalence of common and dysplastic naevi in a Swedish population. Br J Dermatol. 1991;124(2):152\u20136.","journal-title":"Br J Dermatol"},{"issue":"4","key":"444_CR73","first-page":"1855","volume":"45","author":"JJ Nordlund","year":"1985","unstructured":"Nordlund JJ, Kirkwood J, Forget BM, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res. 1985;45(4):1855\u201361.","journal-title":"Cancer Res"},{"issue":"5","key":"444_CR74","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/000155500459259","volume":"80","author":"P Karlsson","year":"2000","unstructured":"Karlsson P, Stenberg B, Rosdahl I. Prevalence of pigmented naevi in a Swedish population living close to the Arctic Circle. Acta Derm Venereol. 2000;80(5):335\u20139.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"444_CR75","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0190-9622(87)70230-8","volume":"17","author":"EA Holly","year":"1987","unstructured":"Holly EA, Kelly JW, Shpall SN, et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol. 1987;17(3):459\u201368.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"444_CR76","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0091-7435(88)90003-5","volume":"17","author":"GC Roush","year":"1988","unstructured":"Roush GC, Nordlund JJ, Forget B, et al. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma. Prev Med. 1988;17(3):273\u20139.","journal-title":"Prev Med"},{"issue":"4","key":"444_CR77","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1158\/1055-9965.EPI-12-1346","volume":"22","author":"AM Goldstein","year":"2013","unstructured":"Goldstein AM, Tucker MA. Dysplastic nevi and melanoma. Cancer Epidemiol Biomark Prev. 2013;22(4):528\u201332.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"444_CR78","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/(SICI)1097-0215(19960807)67:4<485::AID-IJC4>3.0.CO;2-O","volume":"67","author":"AE Grulich","year":"1996","unstructured":"Grulich AE, Bataille V, Swerdlow AJ, et al. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer. 1996;67(4):485\u201391.","journal-title":"Int J Cancer"},{"issue":"6","key":"444_CR79","doi-asserted-by":"crossref","first-page":"777","DOI":"10.5021\/ad.2016.28.6.777","volume":"28","author":"IJ Moon","year":"2016","unstructured":"Moon IJ, Won CH, Lee MW, et al. Eruptive benign melanocytic nevi formation following adalimumab therapy in a patient with Crohn\u2019s disease. Ann Dermatol. 2016;28(6):777\u20139.","journal-title":"Ann Dermatol"},{"issue":"6","key":"444_CR80","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1111\/jdv.14784","volume":"32","author":"Y Mansour","year":"2018","unstructured":"Mansour Y, Lambert A, Tebacher-Alt M, et al. Eruptive nevi under tocilizumab: first case report and data analysis. J Eur Acad Dermatol Venereol. 2018;32(6):e253\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"444_CR81","first-page":"516","volume":"16","author":"AV Prabhu","year":"2017","unstructured":"Prabhu AV, Bibee K, English JC. Eruptive melanocytic acral nevi in the setting of 6-mercaptopurine therapy. J Drugs Dermatol. 2017;16(5):516\u20138.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"444_CR82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/ced.13276","volume":"43","author":"G Kravvas","year":"2018","unstructured":"Kravvas G, Kavanagh GM. Eruptive melanocytic naevi secondary to azathioprine: case report and review of the literature. Clin Exp Dermatol. 2018;43(1):106\u20137.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"444_CR83","first-page":"268","volume":"99","author":"SA Steinweg","year":"2017","unstructured":"Steinweg SA, Halvorson CR, Kao GF, et al. Eruptive melanocytic nevi during azathioprine therapy for antisynthetase syndrome. Cutis. 2017;99(4):268\u201370.","journal-title":"Cutis"},{"issue":"2","key":"444_CR84","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2230.1988.tb00676.x","volume":"13","author":"JN Barker","year":"1988","unstructured":"Barker JN, MacDonald DM. Eruptive dysplastic naevi following renal transplantation. Clin Exp Dermatol. 1988;13(2):123\u20135.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"444_CR85","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdt015","volume":"24","author":"L Boussemart","year":"2013","unstructured":"Boussemart L, Routier E, Mateus C, et al. Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients. Ann Oncol. 2013;24(6):1691\u20137.","journal-title":"Ann Oncol"},{"issue":"11","key":"444_CR86","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamadermatol.2014.838","volume":"150","author":"FW Chen","year":"2014","unstructured":"Chen FW, Tseng D, Reddy S, et al. Involution of eruptive melanocytic nevi on combination BRAF and MEK inhibitor therapy. JAMA Dermatol. 2014;150(11):1209\u201312.","journal-title":"JAMA Dermatol"},{"key":"444_CR87","doi-asserted-by":"crossref","unstructured":"Kong, H.H., V. Sibaud, M.L. Chanco Turner, et al., Sorafenib-induced eruptive melanocytic lesions. Arch Dermatol. 2008;144(6):820\u20132.","DOI":"10.1001\/archderm.144.6.820"},{"issue":"3","key":"444_CR88","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1590\/S0365-05962011000300010","volume":"86","author":"F Santiago","year":"2011","unstructured":"Santiago F, Goncalo M, Reis JP, et al. Adverse cutaneous reactions to epidermal growth factor receptor inhibitors: a study of 14 patients. An Bras Dermatol. 2011;86(3):483\u201390.","journal-title":"An Bras Dermatol"},{"issue":"1","key":"444_CR89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/CMR.0000000000000127","volume":"25","author":"RM Anforth","year":"2015","unstructured":"Anforth RM, Carlos GR, Scolyer RA, et al. Eruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanoma. Melanoma Res. 2015;25(1):91\u20134.","journal-title":"Melanoma Res"},{"issue":"6","key":"444_CR90","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jaad.2012.04.008","volume":"67","author":"EY Chu","year":"2012","unstructured":"Chu EY, Wanat KA, Miller CJ, et al. Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study. J Am Acad Dermatol. 2012;67(6):1265\u201372.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"444_CR91","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/ijd.13717","volume":"56","author":"A Calleja-Algarra","year":"2017","unstructured":"Calleja-Algarra A, Aragon-Miguel R, Velasco-Tamariz V, et al. Eruptive nevi in a patient with metastatic breast cancer. Int J Dermatol. 2017;56(12):1508\u20139.","journal-title":"Int J Dermatol"},{"issue":"6703","key":"444_CR92","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/bmj.299.6703.854-d","volume":"299","author":"B Hughes","year":"1989","unstructured":"Hughes B, Bailey CC. Excess benign melanocytic naevi. BMJ. 1989;299(6703):854\u20135.","journal-title":"BMJ"},{"issue":"6","key":"444_CR93","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4103\/0019-5154.91842","volume":"56","author":"SB Dertlioglu","year":"2011","unstructured":"Dertlioglu SB, Bitiren M, Cicek D. A case with postchemotherapy eruptive compound nevus. Indian J Dermatol. 2011;56(6):737\u20139.","journal-title":"Indian J Dermatol"},{"issue":"1","key":"444_CR94","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1684\/ejd.2013.2227","volume":"24","author":"F Schulze","year":"2014","unstructured":"Schulze F, Erdmann H, Hardkop LH, et al. Eruptive naevi and darkening of pre-existing naevi 24\u00a0h after a single mono-dose injection of melanotan II. Eur J Dermatol. 2014;24(1):107\u20139.","journal-title":"Eur J Dermatol"},{"issue":"3","key":"444_CR95","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2133.2009.09362.x","volume":"161","author":"P Cousen","year":"2009","unstructured":"Cousen P, Colver G, Helbling I. Eruptive melanocytic naevi following melanotan injection. Br J Dermatol. 2009;161(3):707\u20138.","journal-title":"Br J Dermatol"},{"issue":"4","key":"444_CR96","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.adengl.2012.05.002","volume":"103","author":"L. Hueso-Gabriel","year":"2012","unstructured":"Hueso-Gabriel L, Mahiques Santos L, Terradez Mas L, et al. [Eruptive dysplastic nevi following melanotan use]. Actas Dermosifiliogr. 2012;103(4):329\u201331.","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"issue":"5","key":"444_CR97","first-page":"148","volume":"106","author":"C Reid","year":"2013","unstructured":"Reid C, Fitzgerald T, Fabre A, et al. Atypical melanocytic naevi following melanotan injection. Ir Med J. 2013;106(5):148\u20139.","journal-title":"Ir Med J"},{"issue":"4","key":"444_CR98","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1067\/mjd.2001.112217","volume":"44","author":"JW Bauer","year":"2001","unstructured":"Bauer JW, Schaeppi H, Kaserer C, et al. Large melanocytic nevi in hereditary epidermolysis bullosa. J Am Acad Dermatol. 2001;44(4):577\u201384.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"444_CR99","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1590\/S0365-05962011000400023","volume":"86","author":"CP Cotrim","year":"2011","unstructured":"Cotrim CP, Simone FT, Lima RB, et al. Epidermolysis bullosa nevus: case report and literature review. An Bras Dermatol. 2011;86(4):767\u201371.","journal-title":"An Bras Dermatol"},{"issue":"3","key":"444_CR100","first-page":"237","volume":"12","author":"Juliana Dum\u00eat Fernandes","year":"2014","unstructured":"Fernandes JD, Rivitti-Machado MC, Nakano J et al. Clinical, dermoscopic and histopathological features of melanocytic nevi in dystrophic epidermolysis bullosa. J Dtsch Dermatol Ges. 2014;12(3):237\u201342, 237\u201343.","journal-title":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft"},{"issue":"8","key":"444_CR101","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1346-8138.2009.00674.x","volume":"36","author":"H Sugiyama-Fukamatsu","year":"2009","unstructured":"Sugiyama-Fukamatsu H, Suzuki N, Nakanishi G, et al. Epidermolysis bullosa nevus arising in a patient with Dowling-Meara type epidermolysis bullosa simplex with a novel K5 mutation. J Dermatol. 2009;36(8):447\u201352.","journal-title":"J Dermatol"},{"issue":"3","key":"444_CR102","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000334832","volume":"3","author":"Laura Abdo Nalon de Queiroz Fuscaldi","year":"2011","unstructured":"de Queiroz Fuscaldi LA, Bucard AM, Alvarez CD et al. Epidermolysis bullosa nevi: report of a case and review of the literature. Case Rep Dermatol. 2011;3(3):235\u20139.","journal-title":"Case Reports in Dermatology"},{"key":"444_CR103","doi-asserted-by":"crossref","unstructured":"Collantes-Rodriguez C, Jimenez-Gallo D, Arjona-Aguilera C, et al. Eruptive melanocytic nevi in a patient with toxic epidermal necrolysis-like cutaneous lupus. Lupus. 2018:961203317751064.","DOI":"10.1177\/0961203317751064"},{"issue":"4","key":"444_CR104","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0190-9622(99)70460-3","volume":"40","author":"A Firooz","year":"1999","unstructured":"Firooz A, Komeili A, Dowlati Y. Eruptive melanocytic nevi and cherry angiomas secondary to exposure to sulfur mustard gas. J Am Acad Dermatol. 1999;40(4):646\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"444_CR105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0190-9622(79)80092-4","volume":"1","author":"K Soltani","year":"1979","unstructured":"Soltani K, Bernstein JE, Lorincz AL. Eruptive nevocytic nevi following erythema multiforme. J Am Acad Dermatol. 1979;1(6):503\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"444_CR106","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1525-1470.2010.01353.x","volume":"28","author":"T Mollet","year":"2011","unstructured":"Mollet T, Henderson FW, Groben PA, et al. Epidermolysis bullosa nevus-like lesions in a pediatric patient with pyoderma gangrenosum. Pediatr Dermatol. 2011;28(1):32\u20134.","journal-title":"Pediatr Dermatol"},{"key":"444_CR107","unstructured":"Katoulis AC, Sgouros D, Argenziano G, et al. Surgical suturing-induced melanocytic nevi. A new type of eruptive melanocytic nevi? J Dermatol Case Rep. 2016;10(3):49\u201352."},{"issue":"4","key":"444_CR108","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000276983","volume":"220","author":"AA Navarini","year":"2010","unstructured":"Navarini AA, Kolm I, Calvo X, et al. Trauma as triggering factor for development of melanocytic nevi. Dermatology. 2010;220(4):291\u20136.","journal-title":"Dermatology"},{"issue":"1","key":"444_CR109","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5826\/dpc.0801a16","volume":"8","author":"A Tareen","year":"2018","unstructured":"Tareen A, Pallesen K, Vestergaard T. Eruptive nevi after burn injury. Dermatol Pract Concept. 2018;8(1):66\u20137.","journal-title":"Dermatol Pract Concept"},{"issue":"4","key":"444_CR110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-4362.1991.tb04645.x","volume":"30","author":"I Betlloch","year":"1991","unstructured":"Betlloch I, Amador C, Chiner E, et al. Eruptive melanocytic nevi in human immunodeficiency virus infection. Int J Dermatol. 1991;30(4):303.","journal-title":"Int J Dermatol"},{"issue":"9","key":"444_CR111","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/archderm.126.9.1239","volume":"126","author":"HH Ibsen","year":"1990","unstructured":"Ibsen HH, Clemmensen O. Eruptive nevi in Addison\u2019s disease. Arch Dermatol. 1990;126(9):1239\u201340.","journal-title":"Arch Dermatol"},{"issue":"8","key":"444_CR112","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/ced.12133","volume":"38","author":"I Koelemij","year":"2013","unstructured":"Koelemij I, Massolt ET, van Doorn R. Eruptive melanocytic naevi as a sign of primary adrenocortical insufficiency. Clin Exp Dermatol. 2013;38(8):927\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"444_CR113","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jamadermatol.2013.3299","volume":"149","author":"C Surinach","year":"2013","unstructured":"Surinach C, Bahadoran P, Vabres P, et al. Flexural agminated eruptive nevi in Langerhans cell histiocytosis. JAMA Dermatol. 2013;149(5):635\u20137.","journal-title":"JAMA Dermatol"},{"issue":"2 Pt 2","key":"444_CR114","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0190-9622(96)90661-1","volume":"35","author":"S Richert","year":"1996","unstructured":"Richert S, Bloom EJ, Flynn K, et al. Widespread eruptive dermal and atypical melanocytic nevi in association with chronic myelocytic leukemia: case report and review of the literature. J Am Acad Dermatol. 1996;35(2 Pt 2):326\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"444_CR115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdcr.2015.01.002","volume":"1","author":"N Kibbi","year":"2015","unstructured":"Kibbi N, Ariyan S, Slogoff F, et al. Eruptive melanocytic nevi heralding the diagnosis of metastatic malignant melanoma: a case report. JAAD Case Rep. 2015;1(2):74\u20136.","journal-title":"JAAD Case Rep"},{"issue":"5","key":"444_CR116","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/1346-8138.12825","volume":"42","author":"DH Kim","year":"2015","unstructured":"Kim DH, Lee JS, Koo DW, et al. Eruptive melanocytic nevi with satellite lesions following insulin treatment in a girl with type 1 diabetes mellitus. J Dermatol. 2015;42(5):547\u20138.","journal-title":"J Dermatol"},{"issue":"3","key":"444_CR117","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.1977.tb15182.x","volume":"97","author":"RA Eady","year":"1977","unstructured":"Eady RA, Gilkes JJ, Jones EW. Eruptive naevi: report of two cases, with enzyme histochemical, light and electron microscopical findings. Br J Dermatol. 1977;97(3):267\u201378.","journal-title":"Br J Dermatol"},{"key":"444_CR118","unstructured":"J H. Outbreak of a large crop of moles. Remarks as to possible connection with melanosis. J Cutan Med Dis Skin. 1868;170\u20131."},{"issue":"5","key":"444_CR119","doi-asserted-by":"crossref","first-page":"644","DOI":"10.5021\/ad.2017.29.5.644","volume":"29","author":"WK Lee","year":"2017","unstructured":"Lee WK, Jin H, You HS, et al. Eruptive melanocytic nevi without any trigger in a 5-year-old healthy girl. Ann Dermatol. 2017;29(5):644\u20136.","journal-title":"Ann Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00444-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-019-00444-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00444-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T12:34:52Z","timestamp":1663504492000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-019-00444-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1007\/s40257-019-00444-8","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"22 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were used to conduct this review or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"EB and GJ have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}